Cook Medical Holdings LLC, headquartered in the United States, is a prominent player in the global medical device industry. Founded in 1963, the company has established itself as a leader in innovative healthcare solutions, particularly in the fields of vascular intervention, urology, and gastroenterology. With a strong presence in North America, Europe, and Asia, Cook Medical is renowned for its commitment to developing high-quality products that enhance patient care. Their core offerings include advanced catheters, stents, and surgical instruments, distinguished by their reliability and cutting-edge technology. Cook Medical's dedication to research and development has led to numerous milestones, solidifying its market position as a trusted provider of medical devices. The company continues to make significant contributions to the healthcare sector, focusing on improving outcomes for patients worldwide.
How does Cook Medical Holdings Llc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cook Medical Holdings Llc's score of 27 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Cook Medical Holdings LLC reported total carbon emissions of approximately 3,250 kg CO2e, comprising 2,000 kg CO2e from Scope 1, 1,000 kg CO2e from Scope 2, and 250 kg CO2e from Scope 3 emissions. This marks a significant reduction from previous years, with emissions decreasing from about 5,500 kg CO2e in 2018 to the latest figure, demonstrating a commitment to lowering their carbon footprint. The company has shown a consistent downward trend in emissions over the years, with Scope 1 emissions decreasing from 6,000 kg CO2e in 2018 to 2,000 kg CO2e in 2022, and Scope 2 emissions dropping from 3,000 kg CO2e to 1,000 kg CO2e in the same period. Scope 3 emissions also saw a reduction from 2,000 kg CO2e in 2018 to 250 kg CO2e in 2022. Despite the positive trajectory in emissions reduction, Cook Medical has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of formal reduction targets suggests that while the company is actively reducing emissions, it may not yet have committed to specific, measurable goals for future reductions. Overall, Cook Medical's emissions data reflects a proactive approach to climate commitments, aligning with industry standards for sustainability and carbon management.
Access structured emissions data, company-specific emission factors, and source documents
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
Scope 1 | 6,000 | 0,000 | 0,000 | 0,000 | 0,000 |
Scope 2 | 3,000 | 0,000 | 0,000 | 0,000 | 0,000 |
Scope 3 | 2,000 | 0,000 | 0,000 | 000 | 000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cook Medical Holdings Llc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.